Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Recombinant E. coli Fermentation. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN115851559A reveals a novel recombinant E. coli route for 3,4-DHBA. Discover cost-effective biosynthesis solutions and supply chain advantages for chiral intermediates.
Patent CN103642747A details a high-efficiency recombinant E. coli method for chiral alcohol production, offering superior ee >99% and cost-effective cofactor regeneration for pharma supply chains.